Autolus Therapeutics
AUTL1.9955.00% ( +0.095 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Autolus Therapeutics(AUTL) predict that the Revenue is 26.22 M (+191.9%), Beat estimate;the EBIT is -59.51 M (+8.77%), Beat estimate;the EPS is -0.27 (-3.85%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.03B191.89%
0.03B190.94%
+0.00B0.95%
EBITExceed expectations
-0.06B8.77%
-0.07B1.00%
+0.01B9.77%
EPSMiss expectations
-0.273.85%
-0.25481.99%
-0.01525.84%
Upcoming earnings report - FY2026 Q2 Earning Release
Available dateAug 11, 2026
Estimate Revenue40.15 M
Estimate EBIT-48.03 M
Estimate EPS-0.1883
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf